CVS Buys Oak avenue well being, Beats Earnings Estimates

CVS well being

is procuring for

Oak avenue well being

in an all-money transaction. The healthcare agency additionally beat analysts’ estimates for fourth-quarter earnings.

CVS (ticker: CVS) pays $39 a share, valuing Oak avenue (OSH) at an enterprise worth of $10.6 billion, the agency acknowledged Wednesday. CVS acknowledged it can fund the transaction with accessible sources and current financing performance.


Post a Comment